Congfen Li

Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes

Helen E. Heslop, Catherine Y. Ng, Congfen Li et al. · Nature Medicine · 1996 · 833 citations

Life Sciences, Immunology, Infectious Diseases +13

High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade

Kobe Yuen, Lifen Liu, Vinita Gupta et al. · Nature Medicine · 2020 · 439 citations · Full text

Life Sciences, Immunology, Oncology +16

Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial

Thomas Sandmann, Richard Bourgon, Josep Garcia et al. · Journal of Clinical Oncology · 2015 · 293 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

CD8+ T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy

Mahrukh Huseni, Lifen Wang, Joanna E. Klementowicz et al. · Cell Reports Medicine · 2023 · 183 citations · Full text

Life Sciences, Immunology, Oncology +17

Production of Genetically Modified Epstein-Barr Virus-Specific Cytotoxic T Cells for Adoptive Transfer to Patients at High Risk of EBV-Associated Lymphoproliferative Disease

Colton A. Smith, Catherine Y. Ng, Helen E. Heslop et al. · Journal of Hematotherapy · 1995 · 138 citations

Medicine, Hematology, Immunology +14